# Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients

> **NCT04103645** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 2 (actual)

## Conditions studied

- Myeloproliferative Neoplasm

## Interventions

- **DRUG:** Vactosertib
- **DRUG:** Vactosertib
- **DRUG:** Vactosertib
- **DRUG:** Vactosertib
- **DRUG:** Vactosertib

## Key facts

- **NCT ID:** NCT04103645
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-22
- **Primary completion:** 2024-07-10
- **Final completion:** 2024-07-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04103645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04103645, "Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04103645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*